X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Kevin J. McKeon of Hawke McKeon & Sniscak. Kevin J. McKeon of Hawke McKeon & Sniscak.

Litigation has improved Pennsylvania’s medical marijuana research program. The program, Chapter 20 of the Medical Marijuana Act, pairs medical school/teaching hospitals with businesses that grow and dispense medical marijuana. Originally enacted as part of the act in April 2016, Chapter 20 allowed for licensing of teaching hospitals associated with medical schools to do research (dubbed Academic Clinical Research Centers or ACRCs) and offered eight permits to businesses that would grow and dispense medical marijuana (clinical registrants or CRs) for clinical trial purposes. Entities approved as CRs would have a grower/processor permit and a “super” dispensary permit providing six dispensary locations rather than the three allowed for commercial dispensary permittees. But while Chapter 20 of the act made clear its primary focus was on research, it left important questions unanswered. Could CRs compete with other medical marijuana permittees for commercial sales? Did a CR applicant need to have a contract with an ACRC before it could apply for CR status? Did the contract need to be exclusive? Did a CR applicant need to have grower/processor and dispensary permits before it could apply for CR status? Two lawsuits, which resulted in one statutory amendment and two additional sets of administrative regulations, appear to have finally produced definitive answers to the questions, a more open CR selection process and CR day-to-day operations that will place research first.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]

 

Wrongful Use of Civil Proceedings Related Torts in PennsylvaniaBook

A comprehensive review of the body of law upon which wrongful use litigation is built, based and written upon years of experience and a close study of the jurisprudence.

Get More Information
 
 

ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.